Navigation Links
Midwives demand that pregnant women should be made to pay for epidurals!

If women demand epidurals during delivery even if not needed they should be asked to pay. This is the latest demand of midwives through the experts at Royal College of Midwives (RCM). They said that this would help stem the// growing number of women asking for the injection.

About 20% of pregnant women in the UK have an epidural, which costs about £500 in a private maternity hospital.

The epidural though relieves pain during child birth, the RCM's education and research committee says women having epidurals are more likely to then need some other form of intervention. Therefore they should be encouraged to avoid it! The intervention that might be needed are using forceps to deliver the baby, or a ventouse pump, which is attached to the baby's head.

The decision of the committee was that women wanting one for non-medical reasons should be forced to pay.

The proposal has been drafted as follows:-

"This conference is concerned about the rising epidural rate. The conference calls on the UK health departments to ensure that epidurals are provided free to women who have a definitive need, and that a fee is levied for all other women who desire an epidural. Last October the Cochrane Review of studies of epidurals found that women who chose them were 40% more likely to need intervention.

It also found that women opting for an epidural were more likely to experience a longer second stage of labour - when the baby is pushed out of the birth canal.

Those women also faced a greater risk of being unable to move for a short time after birth and to experience low blood pressure.” So if accepted women would have to fish out the money or bear the pai.
'"/>




Page: 1

Related medicine news :

1. Disgruntled GPs and Midwives Squabble over Maternity Care.
2. "Make AIDS Therapy affordable" - Physicians demand
3. Shelved bowel-syndrome drug still in demand
4. SARS: Indias drugs in demand
5. Boys demand more than girls, even before birth
6. Increased demand for Bird flu anti-viral drug world wide
7. Nurses In Ontario demands Safe Disposable Needles
8. Huge demand for high street chlamydia tests
9. Scotland lags far behind in meeting the demand of prostate cancer treatment
10. Fuel demand to be met by Bio-diesel
11. Chemotherapy increases the demand for blood components

Post Your Comments:
(Date:12/2/2009)... , , Media Advisory for Thursday, Dec. 3... to Speak at Luncheon Meeting of Army Wounded Warr...nd Helps Vets Adjust ,, WASHINGTON, Dec. 2 /PR... today by the National Organization on Disability:...ors from the Army Wounded Warrior (AW2) program,s ...
(Date:12/2/2009)... , , MORRISTOWN, N.J., Dec. 2 /PRNewswi...E: WPI ) today announced that it has completed t... cash and stock. The purchase creates a financiall...with over $3 billion in annual revenues and operat...several significant benefits to Watson shareholder...
(Date:12/2/2009)... Study found drinking five or more per week prior...WEDNESDAY, Dec. 2 (HealthDay News) -- Women who dr...per week before they conceive increase their risk ...dy indicates. , "Previous studies have shown an...," said study author Dr. Liwei Chen, an assistant ...
(Date:12/2/2009)... , , CHICAGO, Dec. 2 /PRNewswire-USNewswir...mmography Guidelines Controversy ,, A special ...10:45 a.m. CT (11:45 a.m. ET), featuring a panel o...ventive Services Task Force (USPSTF) release of re...nts, breast cancer survivors, medical experts and ...
(Date:12/2/2009)... , Links Medical Products...or hospitals and nursing homes, announces the open.... The new facility is located at 9247 Research Dri...edical maintains another facility in the Irvine Sp... in Indio, California. This most recent expansion ...
Breaking Medicine News(10 mins):Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5Health News:Sugary Colas Tied to Gestational Diabetes 2Health News:Sugary Colas Tied to Gestational Diabetes 3Health News:Wednesday, Dec. 2: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Health News:Wednesday, Dec. 2: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3
...CK, Mass. and BARRINGTON, Ill., Nov. 6 ,Boston Sci...e (NYSE: GE ),today announced the industry,s firs...m management remote monitoring system and a physic...ientific,s LATITUDE(R) Patient Management,system t...
...TON, Nov. 6 RigNet, Inc., a leading global provid...tream oil and gas industry,and the telemedicine ve...ip,this week at the Offshore Communications Confer...m offshore or to remote,locations. "Access to qua...
...x Rivers Healthcare NHS Trust Implements Ericom,s ...erTerm(R) WebConnect, CLOSTER, N.J., and WORCESTE...ding provider of Enterprise-Wide Application,Acces...s with secure access to the Trust,s central reposi...
...oung people with asthma are about twice as likely ...an are children without asthma, according to a stu...h had suggested a possible link in young people be...tory condition and depressive and anxiety disorder...
...ith National Alzheimers Awareness Month upon us, a...ognitive health in an aging population. Now, resea...oscience 2007 in San Diego shows promise for maint... Research in Alternative and Complementary Medicin...
... a midnight raid on the fridge for junk food -- sl...ealthDay News) -- There,s more bad news about a hi...rnal (circadian) clock, which regulates sleeping, ...thwestern Healthcare (ENH) found that mice fed a h...
Other Medicine News:Health News:Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record 2Health News:Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record 3Health News:Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record 4Health News:Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record 5Health News:RigNet and NuPhysicia Partner to Provide High Tech Health Solutions to Oil and Gas Industry 2Health News:RigNet and NuPhysicia Partner to Provide High Tech Health Solutions to Oil and Gas Industry 3Health News:UK Government (NHS) Selects Ericom to Enable Secure Application Access for its Medical and Administrative Staff 2Health News:Research team finds link between asthma and depressive disorders 2Health News:A 'grape' future for Alzheimer's disease research 2Health News:High-Fat Diet Can Disrupt Body's Clock 2
(Date:12/2/2009)...c. 2 Roche (SIX: RO, ROG...ates Food & Drug Administration (FDA) approved...ic acid test, to screen source plasma in pools com... called the cobas® TaqScreen MPX Test for use...-vitro test for the simultaneous, direct detection...
(Date:12/2/2009)...N.J., Dec. 2 Novartis announced to...ntation on Tasigna® (nilotinib) 200 mg capsul...ate the strength of the company,s hematology portf... new data, at the 51st American Society of Hematol... the company,s current therapies and investigation...
(Date:12/1/2009)...Dec. 1 Reproductive Partners Medic...ryo Transfer (eSET) Encouragement Program to provi...bryo quality and a good prognosis for success to c...ng a single embryo. ,, The biggest issue in adv...e number of multiple pregnancies, even twin pregna...
Breaking Medicine Technology:FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2Strep B Seems to Trick Immune System 51448 1InteKrin Therapeutics Announces Appointment of Geoffrey M Parker as Chief Business Officer 51443 1InteKrin Therapeutics Announces Appointment of Geoffrey M Parker as Chief Business Officer 51443 2Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 1Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 2Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 3Gentiva 28R 29 Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday July 30 2009 51438 4
...armaceuticals, Inc. (Nasdaq: RIGL ) announced tod... 1 study to evaluate the safety and,tolerability o...anus Kinase,3 (JAK3), as a potential treatment for...s and other immune disorders. In preclinical studi...hritic symptoms, bone destruction,and swelling. It...
...omach. Whatever illness it is, it can make you fee...ther but it is even more difficult to handle,being...rican Diabetes Association (ADA), people with,diab...s complications if,they don,t take care of their d...ease to dangerous levels if left unchecked. Ketone...
Other Medicine Technology:Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 2Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 3Help! I'm Sick. How Do I Handle My Diabetes? 2
A.I.med's medical billing software
athenaCollector™
Infinity Uric Acid (Liquid)
Infinity Lithium
Medicine Products: